Grants and Contributions:
Title:
Feasibility of Implant Device
Agreement Number:
980891
Agreement Value:
$50,000.00
Agreement Date:
Nov 1, 2021 - Mar 21, 2022
Description:
The firm is advancing development of their prototyped device for minimally invasive glaucoma surgery. This game changer device will make the treatment of glaucoma safer, more accessible and cost-effective. This project will take the current prototype design and develop it into a final prototype ready for animal testing.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Dieppe, New Brunswick, CA E1A 7R8
Reference Number:
172-2021-2022-Q3-980891
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
766125470
Recipient Type:
For-profit organization
Recipient's Legal Name:
Hexiris Inc.
Federal Riding Name:
Beauséjour
Federal Riding Number:
13002
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
339110